Article info

Download PDFPDF

Original research
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist

Authors

  1. Correspondence to Dr Craig L Slingluff; cls8h{at}virginia.edu
View Full Text

Citation

Meneveau MO, Petroni GR, Salerno EP, et al
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist

Publication history

  • Accepted March 1, 2021
  • First published May 25, 2021.
Online issue publication 
February 07, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.